Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

3D virtual staining technology enables non-invasive observation of cancer tissue

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

We Don't Always Know What's 'Best' for Our Patients

5.

Study opens up possibility of bespoke prostate cancer treatment


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot